ALKERMES | ALKS - 현금 및 동등한





현금 및 동등한 변화 날짜
AbbVie USD 6.57B 2.82B 2026-06
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Biogen USD 1.3B 18.9M 2026-09
BioMarin Pharmaceutical USD 736.01M 138M 2026-09
Bristol-Myers Squibb USD 9.57B 852M 2026-09
Coherus Biosciences USD 82.92M 32.32M 2026-06
Eli Lilly USD 4.89B 4.07B 2026-09
Gilead Sciences USD 3.18B 4.45B 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 16.91B 3.51B 2026-09
Malin Corporation EUR 62.1M 26.4M 2024-12
Merck USD 6.85B 1.52B 2026-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Neurocrine Biosciences USD 641.5M 309.1M 2026-09
Otsuka Holdings JPY 472.49B 2.94B 2026-09
Pfizer USD 976M 727M 2026-06
Regeneron Pharmaceuticals USD 3.66B 1.2B 2026-09
Vertex Pharmaceuticals USD 6.3B 1.55B 2026-09